Geode Capital Management »

Sutro Biopharma shares owned by Geode Capital Management

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $972k 84k 11.58

More positions owned by Geode Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc-cl B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Visa Inc-class A Shares Com Cl A (V)
Johnson & Johnson (JNJ)
Mastercard Inc - A Cl A (MA)

View all positions for Geode Capital Management

Top funds holding Sutro Biopharma

Affinity Asset Advisors
Vanguard Group
Acadian Asset Management
Samsara BioCapital
Eversept Partners
Opaleye Management
Point72 Asset Management
Tang Capital Management
Renaissance Technologies
GSA Capital Partners
Marshall Wace
Geode Capital Management
Longwood Capital Partners
ADAR1 Capital Management
Fisher Investments

View all funds holding Sutro Biopharma